D. M. Parkin, F. Bray, J. Ferlay, and . Pisani-p, Global cancer statistics, CA Cancer J Clin, vol.55, pp.74-108, 2002.

N. J. West, C. E. , P. Ap, and L. Rj, Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention, Cancer epidemiol Biomarkers prev, vol.18, pp.1680-1687, 2009.

F. L. Greene, D. L. Page, I. D. Fleming, A. Fritz, C. M. Balch et al., AJCC (American Joint Committee on Cancer) Cancer staging Manual, p.113, 2002.

H. , Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review, Biochim Biophys Acta, vol.1795, pp.117-129, 2009.

, JC: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms, Nat Clin pract Oncol, vol.3, pp.388-398, 2006.

J. F. Kerr, A. H. Wyllie, and C. Ar, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, vol.26, pp.239-257, 1972.

, Hengartner MO: the biochemistry of apoptosis, Nature Lett, vol.407, pp.770-776, 2000.

. Luo-x, I. Budihardjo, H. Zou, C. Slaughter, and W. , Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors, Cell Death Differ, vol.94, pp.481-490, 1998.

C. Candé, I. Cohen, and . Daugas-e, Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria, Biochimie, vol.84, pp.215-222, 2002.

. Jeong-eg, J. W. Lee, and Y. H. Soung, Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas, ApMIs, vol.114, pp.867-873, 2006.

J. A. Hickman, Different cell thresholds for commitment to death: a link between carcinogenesis and drug resistance, Drug resist Updat, vol.1, pp.84-85, 1998.

G. Roberts, A. W. Darzi, and Z. , Apoptosis and chemo-resistance in colorectal cancer, J surg Oncol, vol.96, pp.77-88, 2007.

C. M. Van-geelen, D. Vries, and D. Jong-s, Lessons from trAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy, Drug resist Updat, vol.7, pp.345-358, 2004.

B. Nachmias, Y. Ashhab, and . Ben-yehuda, D: the inhibitor of apoptosis protein family (IAps): an emerging therapeutic target in cancer. semin, Cancer Biol, vol.14, pp.231-243, 2004.

J. J. Koornstra, D. Jong-s, H. Hollema, D. Vries, and J. H. Kleibeuker, Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature, Crit rev Oncol Hematol, vol.45, pp.37-53, 2003.

Y. Gavrieli, Y. Sherman, and . Ben-sasson, SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, vol.119, pp.493-501, 1992.

C. E. Desch, M. R. Somerfield, and C. Krause, Colorectal cancer surveillance: 2005 update of an American society of Clinical Oncology practice guideline, J Clin Oncol, vol.23, pp.8512-8519, 2005.

J. J. Koornstra, J. H. Kleibeuker, and C. M. Van-geelen, expression of trAIL (tNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas, J pathol, vol.200, pp.327-335, 2003.

A. M. Gown and M. C. Willingham, Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3, J Histochem Cytochem, vol.50, pp.449-454, 2002.

C. H. Wu, M. , and G. J. Safa-ar, beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing Mrp1 but lacking Bax or overexpressing p-glycoprotein, Oncogene, vol.20, pp.7006-7020, 2001.

L. Martin, A. Magnaudeix, F. , Y. , and C. , Inhibition of glycogen synthase kinase-3beta down-regulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A, Brain res Dev Brain res, vol.3, pp.66-75, 2009.

Ø. Hammer, H. Dat, and R. Pd, pAst: paleontological statistics software package for education and Data Analysis, palaeontologia electronica, vol.4, p.9, 2001.

C. G. Fu, O. Nagawa, and H. , role of p53 and p21/ WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients, Dis Colon rectum, vol.41, pp.68-74, 1998.

, Iacopetta B: tp53 mutation in colorectal cancer, Hum Mutat, vol.21, pp.271-276, 2003.

Y. Sy, K. M. Sales, B. Fuller, and M. C. Winslet, Apoptosis and colorectal cancer: implications for therapy, trends Mol Med, vol.15, pp.225-233, 2009.

T. S. Griffith and D. H. Lyncht, TRAIL: a molecule with multiple receptors and control mechanisms, Curr Opin Immunol, vol.10, pp.559-563, 1998.

A. C. Tsamandas and D. Kardamakis, the potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome, Anticancer res, vol.29, pp.703-709, 2009.

C. D. Scopa, A. C. Zolota, V. , and K. Hp, Batistatou A and Vagianos C: potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study, Dig Dis sci, vol.48, 1990.

. Gurzu-s, J. Jung, and M. , the correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas, J Morphol embryol, vol.48, pp.95-99, 2007.

K. Ivanov, N. Kolev, and A. Tonev, Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience, Hepatogastroenterology, vol.56, pp.94-98, 2009.

. Daniels-ra, H. Turley, and F. C. Kimberley, expression of trAIL and trAIL receptors in normal and malignant tissues, Cell res, vol.15, pp.430-438, 2005.

. Oikonomou-e, V. Kosmidou, and A. Katseli, trAIL receptor up-regulation and the implication of KrAs/BrAF mutations in human colon cancer tumors, Int J Cancer, vol.125, pp.2127-2135, 2009.

C. M. Van-geelen, J. L. Westra, and D. Vries-eg, prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients, J Clin Oncol, vol.24, pp.4998-5004, 2006.

A. Bedi and A. J. Akhtar, Inhibition of apoptosis during development of colorectal cancer, Cancer res, vol.55, pp.1811-1816, 1995.

N. K. Kim, J. K. Park, and K. Y. Lee, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer, Ann surg Oncol, vol.8, pp.418-424, 2001.

. El-awady-s, M. Morshed, M. El-shobaky, M. Abo-hashem, and H. Ghazy, potential role of bcl-2 expression and apoptotic body index in colorectal cancer, Hepatogastroenterology, vol.55, pp.76-81, 2008.

H. L. Menezes, M. J. Jucá, . Gomes-eg, B. L. Nunes, C. Ho et al., Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors, Arq Gastroenterol, vol.47, pp.141-147, 2010.